Patients with infections are a leading cause of presentations to the Emergency Department (ED), with severe sepsis and infection causing an estimated 20,000 deaths each day across the world. Treatment is aimed at eradicating the infection and supporting the patient while recovery can take place. Frequently patients develop low blood pressure as a result of immune response that can ultimately result in further organ injury (termed septic shock). Intravenous fluids are recommended by international guidelines as the first line therapy in the ED to treat low blood pressure of sepsis with the hope of preventing organ injury and death. Despite 50 years of use in sepsis, the rationale for fluids remains based in theory rather than clear evidence it is effective in saving lives. Disconcertingly, there is now increasing evidence that fluids in sepsis are ineffective and may actually worsen patient survival. Despite this fluids continue to be recommended and used liberally in the ED resulting in conflict between our historical practice and the best evidence.
We have developed an animal model of septic shock and resuscitation in order to test the effectiveness of fluid resuscitation. This will allow us to both understand the true effect but also investigate the underlying physiological mechanisms of any harms.
The research team successfully developed a laboratory model of endotoxaemic shock for this pre-clinical trial.
Using this model, they found that following fluid resuscitation, significantly more noradrenaline was required to maintain the same mean arterial pressure in the subsequent 12 hours. Atrial natriuretic peptide increased significantly after fluid resuscitation. The rate of increase of the glycocalyx glycosaminoglycan hyaluronan was greater also.
The researchers concluded that fluid resuscitation resulted in a paradoxical increase in vasopressor requirement. Additionally, it did not result in improvements in any of the measured microcirculatory- or organ-specific markers measured. The increase in vasopressor requirement may have been due to endothelial/glycocalyx damage secondary to atrial natriuretic peptide-mediated glycocalyx shedding.
- NHMRC grant: $AUD 980,810.56 (Understanding tissue responses to fluid resuscitation and blood transfusion during ovine sepsis to improve outcomes [ 2014 - 2017 ] Also known as: Resuscitation in Endotoxaemic Shock - Understanding Sepsis (RESUS))
- In-kind: $230,000
- Byrne, L., Obonyo, N.G., Diab, S., Dunster, K., Passmore, M., Boon, A.C., Hoe, L.S., Pedersen S., Fauzi M.H., Pimenta L.P., Hay, K., Van Haren, F., Antsey C.M., Cullen, L., Tung J-P., Shekar, K., Maitland, K., and Fraser, J., “Unintended Consequences; Fluid Resuscitation Worsens Shock in an Ovine Model of Endotoxemia”, American Journal of Respirator and Critical Care Medicine, 2018 June [in press]. doi.org/10.1164/rccm.201801-0064OC
- Byrne, L., Obonyo, N.G., Diab, S., Dunster, K., Passmore, M., Boon, A.C., Hoe, L.S., Hay, K., Van Haren, F., Tung, J.P. and Cullen, L., 2017. "An Ovine Model of Hyperdynamic Endotoxemia and Vital Organ Metabolism", 'Shock', 2018;49(1):99-107. doi: 10.1097/SHK.0000000000000904.